Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Cardiopulmonary Tests Urged for Lasting Fatigue, Dyspnea After COVID-19

News Daily News

Cardiopulmonary Tests Urged for Lasting Fatigue, Dyspnea After COVID-19

December 02, 2021

COVID-19: TCTMD’s Dispatch for November Week 5

News Daily News

COVID-19: TCTMD’s Dispatch for November Week 5

November 29, 2021

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

News Daily News

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

October 15, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

COVID-19: TCTMD’s Dispatch for October Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 2

October 11, 2021

Antithrombotics No Help for Stable COVID-19 Outpatients: ACTIV-4b

News Daily News

Antithrombotics No Help for Stable COVID-19 Outpatients: ACTIV-4b

June 22, 2021

New HF Uncommon After COVID-19, but Rare Cases Pose Quandary

News Daily News

New HF Uncommon After COVID-19, but Rare Cases Pose Quandary

April 28, 2021

Large Registry Reassures on COVID-19’s CV Impact

News Daily News

Large Registry Reassures on COVID-19’s CV Impact

April 22, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.